 |
Corporate News
07-Nov-23
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals allots 78,440 equity shares under ESOS
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has allots 78,440 equity shares under ESOS on 07 November 2023. Consequently, the issued, subscribed and paid up capital (adjusted for split in face value) has increased from 15,49,55,510 equity shares of Re. 1 each to 15,50,33,950 equity shares of Re. 1 each.
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals consolidated net profit rises 25.89% in the December 2023 quarter
(
Results
-
Announcements
06-Feb-24
17:14
)
|
|
|
J B Chemicals & Pharmaceuticals fixes record date for interim dividend
(
Market Beat
-
Reports
06-Feb-24
16:48
)
|
|
|
J B Chemicals & Pharmaceuticals Ltd gains for third consecutive session
(
Hot Pursuit
-
12-Apr-24
13:05
)
|
|
|
J B Chemicals & Pharmaceuticals allots 5,320 equity shares under ESOS
(
Corporate News
-
13-Sep-22
17:37
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit declines 45.56% in the December 2021 quarter
(
Results
-
Announcements
15-Feb-22
08:22
)
|
|
|
J B Chemicals & Pharmaceuticals allots 10,210 equity shares under ESOS
(
Corporate News
-
30-Nov-23
10:34
)
|
|
|
J B Chemicals & Pharmaceuticals standalone net profit rises 24.54% in the September 2021 quarter
(
Results
-
Announcements
12-Nov-21
16:54
)
|
|
|
J B Chemicals & Pharmaceuticals AGM scheduled
(
Corporate News
-
18-Jul-22
10:59
)
|
|
|
B Chemicals & Pharmaceuticals contributes Rs 2 cr for fight against COVID-19
(
Corporate News
-
15-Apr-20
19:23
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 3.29% in the March 2023 quarter
(
Results
-
Announcements
24-May-23
18:02
)
|
|
|
J B Chemicals & Pharmaceuticals completes acquisition of brand Azmarda from Novartis
(
Corporate News
-
12-Apr-22
21:19
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|